ERISNSEEris Lifesciences LimitedLowNeutral
Announced Tue, 13 May · 15:58 IST

Eris Lifesciences Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Eris Lifesciences has scheduled a conference call for analysts and investors on Monday, May 19, 2025, at 4:00 PM IST. The call will be held via webcast to discuss the company's financial and operational performance for Q4 FY25 and the full financial year ending March 31, 2025. This is a follow-up to the board meeting intimation dated May 13, 2025, where the board will consider and approve the audited standalone and consolidated financial results. The webcast link and RSVP contact details have been shared with the exchanges and posted on the company's website.

Likely market impact

This is a routine investor engagement ahead of the Q4 and FY25 results announcement. Shareholders can expect management commentary on earnings and business performance, which may provide forward-looking cues but is not directly price-moving on its own.